Key result
Elevated galectin-3 correlates with myocardial fibrosis severity in a viral myocarditis mouse model.
Why the study?
The pathophysiological role of galectin-3 in acute myocarditis following viral infection is not fully understood.
Does galectin-3 expression correlate with cardiac fibrotic degeneration in an animal model of acute viral myocarditis?
Does galectin-3 expression correlate with cardiac fibrotic degeneration in an animal model of acute viral myocarditis?
Serum galectin-3 may serve as an early diagnostic biomarker for detecting cardiac fibrotic degeneration in acute viral myocarditis.
Answers are grounded in this paper and cite their sources.
Serum galectin-3 may mark early fibrotic degeneration in murine viral myocarditis; leaves open clinical biomarker utility pending human studies.
Galectin-3 is a β-galactoside-binding lectin which is important in cell proliferation and apoptotic regulation. Recently, serum galectin-3 has been shown to have prognostic value as a biomarker in heart failure. Encephalomyocarditis virus (EMCV) can cause severe myocarditis, congestive heart failure and dilated cardiomyopathy as well as encephalitis in various animals including mice. The pathophysiological role of galectin-3 in acute myocarditis following viral infection is not fully understood. The goal of this study is to determine the cardiac localization and the time-course of galectin-3 expression in heart failure after viral inoculation with EMCV. At 12, 24, 48, 96 hours, 7 and 10 days after intraperitoneal EMCV inoculation, animals were examined histologically and analyzed for the expression of galectin-3 and Iba1. Galectin-3 was up-regulated in degenerated fibrotic lesions of cardiac tissues 96 hours after viral inoculation and were followed by myocardial fibrosis. At the same time, Iba1 positive macrophages were observed within the inflammatory sites. A time-course correlation between the number of galectin-3 positive cells and the cardiac area of degenerated fibrotic lesions was detected-serum galectin-3 increased at 96 hours and correlated well with the number of cardiac galectin-3 positive cells. Our results indicate that galectin-3 expression may be a useful biomarker of cardiac fibrotic degeneration in acute myocarditis following viral infection. In addition, measuring serum galectin-3 levels might be an early diagnostic method for detecting cardiac degeneration in acute myocarditis.
No takes yet. Share an insight, caveat, or question.
Noguchi et al. (2019) studied Viral myocarditis (n=42). Encephalomyocarditis virus (EMCV) inoculation vs. Control (uninfected mice) was evaluated on Cardiac and serum galectin-3 levels and myocardial fibrosis (p=<0.05). In a mouse model of viral myocarditis, cardiac galectin-3 expression and serum galectin-3 levels significantly increased 96 hours after EMCV inoculation and correlated positively with the degree of myocardial fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: